Moleculin Biotech, Inc. (MBRX) insider trading.
In Q3 2026, insiders at Moleculin Biotech, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 3 open-market purchases and 0 sales.
- Transactions
- 3
- Purchases (P)
- 3
- Sales (S)
- 0
- Net shares, P minus S
- 999,999
- Insiders
- 3
- Last filed
- 2026-08-05
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Picker Donald H | Officer · Chief Science Officer | 1 | 1 | 0 |
| Klemp Walter V | Director, Officer · CEO and President | 1 | 1 | 0 |
| Foster Jonathan P. | Officer · Chief Financial Officer | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-03 | Picker Donald H | P (A) | 173,333 | — | 174,086 | Form 4 |
| 2026-08-03 | Klemp Walter V | P (A) | 533,333 | — | 564,340 | Form 4 |
| 2026-08-03 | Foster Jonathan P. | P (A) | 293,333 | — | 305,673 | Form 4 |
Transaction codes in this quarter
Get MBRX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1659617&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · MBRX company page · Moleculin Biotech, Inc. on SEC.gov
Questions
Are insiders buying or selling Moleculin Biotech, Inc. (MBRX)?
In Q3 2026, insiders at Moleculin Biotech, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 3 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Moleculin Biotech, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/mbrx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.